Global Nanopore Sequencing Patent Landscape Report 2024

Global Nanopore Sequencing Market Size

The nanopore sequencing market was valued at USD 271.64 million in 2023. It is expected to grow at a CAGR of 11.2% during the forecast period of 2024-2032 and attain a market value of USD 706.21 million in 2032. The market value is impacted by the increasing use of such platforms and ongoing technological advancements in this field. There has been a significant increase in the number of patent applications associated with nanopore sequencing, driven by continued advances in genomics and molecular biology research increasing the demand for innovative sequencing methods as nanopore sequencing.

Patent Landscape Report Coverage

The Global Nanopore Sequencing Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this industry. The key sections captured in the report for “Global Nanopore Sequencing” include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within nanopore sequencing technologies.

Next genome sequencing, single-cell sequencing and quantum sensing technologies are powerful techniques used to integrate nanopore sequencing with other platforms. It can help in providing additional information that combines the strengths of different sequencing methods for a more comprehensive genome analysis. Therefore, such technical innovations have a significant impact on the patent landscape.

Global Nanopore Sequencing Patent Market Outlook

• The increasing number of genetic disorders and the need for accurate diagnosis and personalized medicine are driving the adoption of nanopore sequencing technologies.

• Continuous inventions and innovations for improvements in nanopore sequencing technology, such as better accuracy, speed and read length are attracting more users.

• Nanopore sequencing is increasingly used in various fields, including agriculture, environmental monitoring, and forensics, which expands the scope of this market.

What is Nanopore Sequencing?

Nanopore sequencing is a DNA and RNA sequencing technique that involves transporting nucleic acid molecules through nanoscale pores and detecting changes in electrical conductivity to determine the base sequence. This technique allows for real-time data collection, long read lengths, and direct detection of nucleotide changes. It is highly portable, cost-effective, and requires little sample preparation, making it suitable for a variety of applications in genomics, clinical diagnostics, environmental monitoring, and more.

Nanopore sequencing continues to evolve, driven by the portability and accessibility of nanopore sequencing devices such as MinION allowing them to be used in remote and limited resources, expanding their market reach. The reduced cost of nanopore sequencing compared to traditional sequencing methods makes it more affordable and attractive to a wider user base which is a driving factor to boost market value in the forecast period.

Nanopore Sequencing Industry Growth Drivers

Increasing Technological Innovation in Nanopore Sequencing is Expected to Augment the Market Growth

Continued technological advances in nanopore ordering will significantly drive the market for instruments and accessories. These innovations improve the accuracy, speed, and capabilities of sequencers, making them more attractive to a wider range of users, improving patient outcomes and fueling market growth.

For instance, in 2022, Oxford Nanopore launched its new product PromethION 2 (P2) Solo which offers high-performance sequencing capabilities in a compact form factor. It provides long-read sequencing through real-time data analysis, enabling researchers to sequence large genomes and transcriptomes more efficiently. This advanced device addresses the need for scalable and flexible sequencing solutions in both research and clinical settings.

Increasing Demand for Portable and Point-of-Care (PoC) Sequencing Solutions is Expected to Propel the Nanopore Sequencing Industry Growth

There is a growing demand for portable sequencing solutions that can be used in various environments such as clinical diagnostics, environmental monitoring, and field research. This demand is driving the market for compact, user-friendly nanopore sequencing instruments and related accessories.

Global Nanopore Sequencing Patent Segmentation

The report provides an in-depth analysis of the patents in this field by the following segmentation - 

Breakup by Product

• Consumables

• Instrument

Breakup by Application

• DNA Sequencing

• RNA Sequencing

Nanopore Sequencing Patent Segmentation Analysis

The breakup based on the product includes DNA sequencing and RNA sequencing. CRISPR/Cas is an advanced genomic sequencing technique that can be used to target and enrich specific regions of the genome, improving the sensitivity and specificity of nanopore sequencing to detect mutations and other genetic variations.

The detailed technological data will be provided for all specified segments classified in this report.

Nanopore Sequencing Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for nanopore sequencing patents, having around 16,000 patents. The presence of a well-established healthcare infrastructure, a robust legal framework, and prominent research institutions engaged in innovations contributes to the patent landscape significantly.

China is another significant jurisdiction and is witnessing rapid growth in patent filings. Holding a significant chunk of the global population, the expanding healthcare landscape in the region contributes to the evolving research capabilities, thereby influencing a surge in patent applications.

Patent Profile of Key Companies

Among the players with nanopore sequencing patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Illumina Inc.

A pioneer in the field of genomics with a base of operations in San Diego, California, that specializes in the creation and production of sequencing and array-based products for genetic and genomic analysis. Although Illumina is best known for its short-read sequencing technologies, through partnerships and strategic investments, the company has also dabbled in nanopore sequencing. There are many uses for its genomic solutions in research, clinical diagnostics, and personalized medicine.

Oxford Nanopore Technologies

A leading biotechnology company specializing in the development and commercialization of nanopore sequencing technology. Their platforms, including the portable MinION and high-throughput PromethION, provide real-time, scalable sequencing solutions that provide long read data and directly detect base changes. Oxford Nanopore technology is widely used in research, clinical diagnostics, environmental monitoring, and other tasks, promoting innovations in genomics and molecular biology.

Other companies include Cyclomics BV, Grandomics Biosciences Co., Ltd, Electronic Biosciences LLC., and INanoBio Inc, INC among others.

Reasons to Purchase this Report

The global nanopore sequencing patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and also makes it understandable which companies have important patents in this field of nanopore sequencing.
• Innovation Insights: The patent analysis reveals new innovations and technologies in nanopore sequencing industry.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry.

• Risk Assessment: In technology-intensive fields such as pumps for microfluidic devices, risks of IP infringement are common. Analysing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

• Legal and Regulatory Compliance: Understanding the patent landscape is critical to ensuring compliance with patent laws and regulations. It helps stakeholders navigate license agreements, avoid infringement lawsuits, and effectively use IP assets in a global marketplace.

Key Questions Answered in the Global Nanopore Sequencing Patent Landscape Report

• Who are the key players in the nanopore sequencing patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in nanopore sequencing patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the nanopore sequencing industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in nanopore sequencing?
• What are the challenges and opportunities in the nanopore sequencing patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in nanopore sequencing?

Related Reports

Global Nanopore Technologies Market

Global Next Generation Sequencing Market

Global DNA Sequencing Products Market

Global Microbiome Sequencing Services Market

Global DNA Synthesizer Market